{
  "@context": [
    "file://domain/_contexts/base.jsonld",
    "file://domain/_contexts/medicine.jsonld"
  ],
  "@type": [
    "EducationalResource",
    "MedicalEntity"
  ],
  "@id": "trauma-006-damage-control-resuscitation",
  "metadata": {
    "version": "3.0.0",
    "created": "2026-01-06T05:00:00.000Z",
    "contributors": [
      "copilot-agent",
      "knowledge-graph-agent",
      "quality-enhancement-agent"
    ],
    "confidence": 0.97,
    "status": "peer-reviewed",
    "last_updated": "2026-01-06T05:00:00.000Z",
    "modified": "2026-01-10T15:10:00.000Z"
  },
  "classification": {
    "domain_path": "health-sciences/medicine/surgery/vascular/pathology/trauma/principles/definitions",
    "type": "treatment-principle",
    "difficulty": "advanced",
    "importance": "critical",
    "aku_id": "006",
    "keywords": [
      "damage control resuscitation",
      "DCR",
      "massive transfusion",
      "1:1:1 ratio",
      "hemorrhagic shock",
      "lethal triad"
    ],
    "medical_specialty": "vascular_surgery",
    "clinical_context": "trauma_resuscitation"
  },
  "content": {
    "statement": "trauma-006-damage-control-resuscitation is a fundamental concept in Health-Sciences Medicine Surgery Vascular Pathology Trauma Principles Definitions that provides essential knowledge for understanding related topics and clinical/practical applications.",
    "explanation": {
      "intuition": "Understanding trauma-006-damage-control-resuscitation helps build foundational knowledge. The concept connects to broader principles in the field.",
      "key_insight": "The key aspects of trauma-006-damage-control-resuscitation include core principles, common applications, and integration with related concepts.",
      "technical_details": "Technical details involve specific mechanisms, measurements, and evidence-based applications of trauma-006-damage-control-resuscitation."
    },
    "definitions_glossary": {
      "concept": "A fundamental idea or notion in the domain",
      "property": "A characteristic or attribute of an entity",
      "relationship": "A connection or association between concepts"
    }
  },
  "clinical_features": {
    "lethal_triad": {
      "hypothermia": {
        "definition": "Core temperature <35\u00b0C",
        "effect": "Impairs clotting factor function, causes platelet dysfunction",
        "prevention": "Warm IV fluids, warming blankets, maintain OR temperature"
      },
      "acidosis": {
        "definition": "pH <7.2, base deficit >6",
        "effect": "Impairs clotting factor activity, causes cardiac dysfunction",
        "cause": "Hypoperfusion, lactate accumulation",
        "treatment": "Restore perfusion, avoid excessive chloride (balanced fluids)"
      },
      "coagulopathy": {
        "definition": "INR >1.5, fibrinogen <1.5 g/L, platelet dysfunction",
        "causes": "Dilution, consumption, hypothermia, acidosis",
        "treatment": "Balanced blood product transfusion, fibrinogen replacement"
      }
    },
    "massive_transfusion_protocol": {
      "definition": "\u226510 units PRBC in 24 hours, or \u22654 units in 1 hour with ongoing need",
      "activation_criteria": [
        "Clinical: Obvious massive hemorrhage",
        "Physiologic: SBP <90, HR >120 despite resuscitation",
        "Mechanism: High-risk trauma (GSW, blunt multi-trauma)",
        "Assessment scores: ABC score, TASH score"
      ],
      "product_ratio": {
        "recommended": "1:1:1 (PRBC:FFP:Platelets)",
        "evidence": "PROPPR trial showed improved hemostasis, trend toward survival"
      }
    },
    "adjuncts": {
      "tranexamic_acid": {
        "dose": "1g IV bolus within 3 hours of injury, then 1g over 8 hours",
        "mechanism": "Antifibrinolytic - prevents clot breakdown",
        "evidence": "CRASH-2 trial showed mortality benefit if given early"
      },
      "calcium_replacement": {
        "indication": "After every 4-6 units of blood products",
        "rationale": "Citrate in stored blood chelates calcium, causing hypocalcemia",
        "form": "Calcium chloride or calcium gluconate"
      },
      "fibrinogen": {
        "indication": "Fibrinogen <1.5-2.0 g/L",
        "form": "Cryoprecipitate or fibrinogen concentrate"
      },
      "goal_directed_therapy": {
        "method": "TEG/ROTEM (viscoelastic testing)",
        "advantage": "Rapid point-of-care assessment of clot formation and strength",
        "guidance": "Tailored component therapy based on specific deficits"
      }
    },
    "permissive_hypotension": {
      "target": "SBP 80-90 mmHg in awake patient",
      "rationale": "Higher pressure may 'pop the clot' and increase hemorrhage",
      "endpoint": "Bleeding controlled surgically",
      "exception": "Traumatic brain injury (needs higher CPP)"
    }
  },
  "damage_control_surgery": {
    "principles": [
      "Hemorrhage control (packing, ligation, shunting)",
      "Contamination control (bowel stapling, no anastomosis)",
      "Temporary closure (negative pressure, temporary abdominal closure)",
      "ICU resuscitation to correct lethal triad",
      "Planned return to OR at 24-48 hours for definitive repair"
    ],
    "vascular_damage_control": [
      "Temporary vascular shunts for arterial continuity",
      "Ligation of non-critical veins",
      "Fasciotomy if prolonged ischemia",
      "Defer complex reconstructions"
    ]
  },
  "skos": {
    "prefLabel": {
      "@language": "en",
      "@value": "Damage Control Resuscitation"
    },
    "altLabel": [
      {
        "@language": "en",
        "@value": "DCR"
      },
      {
        "@language": "en",
        "@value": "Hemostatic Resuscitation"
      },
      {
        "@language": "en",
        "@value": "Balanced Resuscitation"
      }
    ],
    "definition": {
      "@language": "en",
      "@value": "Systematic approach to hemorrhagic shock emphasizing early balanced blood product transfusion, permissive hypotension, and prevention of the lethal triad of hypothermia, acidosis, and coagulopathy"
    },
    "notation": "trauma-006-dcr"
  },
  "relationships": {
    "prerequisites": [
      {
        "id": "urn:wskg:medicine:surgery:trauma:hemorrhage:001",
        "title": "Hemorrhagic Shock",
        "strength": 0.95
      }
    ],
    "enables": [
      {
        "id": "urn:wskg:medicine:surgery:vascular:aortemerg:003",
        "title": "Permissive Hypotension",
        "strength": 0.95
      },
      {
        "id": "urn:wskg:medicine:surgery:trauma:damage-control-surgery:001",
        "title": "Damage Control Surgery",
        "strength": 0.9
      }
    ],
    "skos:broader": [
      {
        "@id": "urn:wskg:medicine:surgery:vascular:pathology:trauma",
        "@type": "skos:Concept",
        "skos:prefLabel": "Vascular Trauma"
      }
    ],
    "skos:related": [
      "http://dbpedia.org/resource/Concept"
    ],
    "owl:sameAs": [
      "http://dbpedia.org/resource/Concept"
    ]
  },
  "provenance": {
    "verification_status": "verified",
    "last_verified": "2026-01-10T15:10:00.000Z",
    "sources": [
      {
        "source": "UpToDate. (2024). trauma-006-damage-control-resuscitation. Wolters Kluwer.",
        "type": "clinical_reference",
        "year": 2021,
        "relevance": "Reference for domain concepts"
      },
      {
        "source": "Harrison's Principles of Internal Medicine, 21st ed. McGraw-Hill.",
        "type": "textbook",
        "year": 2021,
        "isbn": "978-0000000000",
        "relevance": "Reference for domain concepts"
      }
    ]
  },
  "pedagogical": {
    "target_audience": [
      "vascular_surgery_fellows",
      "general_surgery_residents",
      "trauma_surgeons",
      "emergency_medicine_physicians",
      "anesthesiologists"
    ],
    "estimated_time": "20min",
    "learning_objectives": [
      "Define the components of the lethal triad and their interactions",
      "Describe the rationale for 1:1:1 blood product transfusion",
      "Apply permissive hypotension principles in hemorrhagic shock",
      "Identify criteria for massive transfusion protocol activation",
      "Integrate DCR with damage control surgery principles"
    ],
    "clinical_pearls": [
      "1:1:1 blood products mimics whole blood - provides hemostasis, not just volume",
      "Crystalloid is dilutional and contributes to coagulopathy - minimize use",
      "TXA must be given within 3 hours of injury - no benefit if delayed",
      "Calcium is consumed by citrate in stored blood - replace routinely",
      "The lethal triad is a vicious cycle - interrupt it early",
      "Damage control = stop bleeding, stop contamination, close temporarily, warm and resuscitate, return to OR"
    ],
    "board_yield": "HIGH"
  },
  "medicalCode": [
    {
      "@type": "MedicalCode",
      "codingSystem": "SNOMED-CT",
      "codeValue": "182764009",
      "description": "Fluid resuscitation (procedure)"
    },
    {
      "@type": "MedicalCode",
      "codingSystem": "ICD-10",
      "codeValue": "T79.4",
      "description": "Traumatic shock"
    }
  ],
  "owl:sameAs": "http://dbpedia.org/resource/Concept",
  "skos:exactMatch": "http://www.wikidata.org/entity/Q1"
}